Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Kano, Keisuke*; Saruya, Ryota*; Kawabata, Shunsuke*; Araki, Jun*; Noguchi, Katsuya*; Kada, Wataru*; Miura, Kenta*; Kato, Hijiri*; Sato, Takahiro; Koka, Masashi; et al.
no journal, ,
Kawabata, Shunsuke*; Saruya, Ryota*; Kato, Hijiri*; Araki, Jun*; Miura, Kenta*; Kada, Wataru*; Sato, Takahiro; Koka, Masashi; Ishii, Yasuyuki; Kamiya, Tomihiro; et al.
no journal, ,
no abstracts in English
Fujino, Shunsuke; Hashimoto, Kazuyuki; Saeki, Hideya*; Kawauchi, Yukimasa*; Kawabata, Masako*; Chiba, Yusuke
no journal, ,
Lutetium-177 (Lu-177)is a medical radioisotope used in approved radiopharmaceutical "Lutathera" to treat neuroendocrine tumours. And it is one of the promising radionuclides for new therapeutic radiopharmaceuticals. However, Lu-177 is dependent on imports from overseas, and there are concerns that transportation problems etc. may affect domestic distribution and development of new pharmaceuticals. In order to confirm whether JAEA can produce a portion of the Lu-177 for research, we conducted a production test of Lu-177 using JRR-3.